The historical rank and industry rank for Apontis Pharma AG's Days Payable or its related term are showing as below:
FRA:APPH'
s Days Payable Range Over the Past 10 Years
Min: 65.68 Med: 84.27 Max: 138.25
Current: 72.82
During the past 7 years, Apontis Pharma AG's highest Days Payable was 138.25. The lowest was 65.68. And the median was 84.27.
FRA:APPH's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 90.835
vs FRA:APPH: 72.82
Apontis Pharma AG's Days Payable
declined
from Jun. 2024 (108.07) to Jun. 2025 (70.62).
It may suggest that Apontis Pharma AGaccelerated paying its suppliers.
Apontis Pharma AG Days Payable Related Terms
Apontis Pharma AG Days Payable Historical Data
* Premium members only.
The historical data trend for Apontis Pharma AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:APPH vs ZTS, UTHR, NBIX: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Apontis Pharma AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apontis Pharma AG Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Apontis Pharma AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Apontis Pharma AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Apontis Pharma AG's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apontis Pharma AG (FRA:APPH) has a Days Payable of 70.62 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Apontis Pharma AG and its competitors. This is 16% below median its historical median of 84.27. Over the past decade, Apontis Pharma AG's Days Payable has ranged from 65.68 to 138.25.
Is Apontis Pharma AG's Days Payable too high?
Apontis Pharma AG's current Days Payable of 70.62 is 16% below median its 10-year median of 84.27. Over the past 10 years, this metric has ranged from a low of 65.68 to a high of 138.25. The Drug Manufacturers industry median Days Payable is 90.84. Apontis Pharma AG's value of 70.62 is 22.3% below this industry median. Overall, Apontis Pharma AG has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Apontis Pharma AG's Days Payable compare to ZTS and UTHR?
Apontis Pharma AG's Days Payable of 70.62 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.84. Apontis Pharma AG's value of 70.62 is 22.3% below this benchmark. Historically, Apontis Pharma AG's own Days Payable has ranged from 65.68 to 138.25 over the past decade. While the company's 10-year median is 84.27 vs. the industry median of 90.84, Apontis Pharma AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apontis Pharma AG's current Days Payable of 70.62 is 22.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Apontis Pharma AG and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apontis Pharma AG's current Days Payable is 70.62, which is 16% below median its own 10-year median of 84.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apontis Pharma AG stock overvalued right now?
Apontis Pharma AG (FRA:APPH) has a current Days Payable of 70.62. The stock's GF Value™ is €10.46, compared to a current price of €11.00 — trading 5.2% above its estimated fair value. The current Days Payable is 70.62, which is 16% below median its 10-year median of 84.27 and 22.3% below the Drug Manufacturers industry median of 90.84. Apontis Pharma AG's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Apontis Pharma AG (FRA:APPH), the current Days Payable is 70.62 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apontis Pharma AG (FRA:APPH) Overvalued in 2026?
Based on GuruFocus' analysis, Apontis Pharma AG stock appears to be overvalued.
The current stock price of €11.00 is trading 5.2% above its estimated GF Value™ of €10.46.
Key valuation signals for FRA:APPH:
Days Payable: 70.62 (16% below median its 10-year median of 84.27)
GF Value™: €10.46 vs. price of €11.00 (5.2% above fair value)
Industry Position: 22.3% below the Drug Manufacturers median
No single metric tells the full story. See the FRA:APPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
17GF Score
Get the complete analysis for FRA:APPH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:APPH has been successfully added to your 
